4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $177.89 million. The enterprise value is -$256.70 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 46.32 million shares outstanding. The number of shares has increased by 28.42% in one year.
| Current Share Class | 46.32M |
| Shares Outstanding | 46.32M |
| Shares Change (YoY) | +28.42% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 3.90% |
| Owned by Institutions (%) | 75.42% |
| Float | 35.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7,734.20 |
| Forward PS | 66.90 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.36, with a Debt / Equity ratio of 0.05.
| Current Ratio | 12.36 |
| Quick Ratio | 11.95 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.97% and return on invested capital (ROIC) is -22.93%.
| Return on Equity (ROE) | -32.97% |
| Return on Assets (ROA) | -22.19% |
| Return on Invested Capital (ROIC) | -22.93% |
| Return on Capital Employed (ROCE) | -41.59% |
| Revenue Per Employee | $101 |
| Profits Per Employee | -$777,264 |
| Employee Count | 227 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.72% in the last 52 weeks. The beta is 2.83, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.83 |
| 52-Week Price Change | -81.72% |
| 50-Day Moving Average | 3.67 |
| 200-Day Moving Average | 6.02 |
| Relative Strength Index (RSI) | 47.20 |
| Average Volume (20 Days) | 510,640 |
Short Selling Information
The latest short interest is 4.17 million, so 9.01% of the outstanding shares have been sold short.
| Short Interest | 4.17M |
| Short Previous Month | 4.35M |
| Short % of Shares Out | 9.01% |
| Short % of Float | 11.79% |
| Short Ratio (days to cover) | 8.76 |
Income Statement
In the last 12 months, FDMT had revenue of $23,000 and -$176.44 million in losses. Loss per share was -$3.18.
| Revenue | 23,000 |
| Gross Profit | -154.11M |
| Operating Income | -203.33M |
| Pretax Income | -109.89M |
| Net Income | -176.44M |
| EBITDA | -198.80M |
| EBIT | -203.33M |
| Loss Per Share | -$3.18 |
Full Income StatementBalance Sheet
The company has $321.44 million in cash and $23.85 million in debt, giving a net cash position of $434.59 million or $9.38 per share.
| Cash & Cash Equivalents | 321.44M |
| Total Debt | 23.85M |
| Net Cash | 434.59M |
| Net Cash Per Share | $9.38 |
| Equity (Book Value) | 469.72M |
| Book Value Per Share | 10.14 |
| Working Capital | 305.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$153.26 million and capital expenditures -$3.71 million, giving a free cash flow of -$156.96 million.
| Operating Cash Flow | -153.26M |
| Capital Expenditures | -3.71M |
| Free Cash Flow | -156.96M |
| FCF Per Share | -$3.39 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -884,026.09% |
| Pretax Margin | -767,126.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.42% |
| Shareholder Yield | -28.42% |
| Earnings Yield | -99.19% |
| FCF Yield | -88.24% |
Analyst Forecast
The average price target for FDMT is $32.33, which is 741.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $32.33 |
| Price Target Difference | 741.93% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 393.82% |
| EPS Growth Forecast (5Y) | 5.46% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 6.75 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.75 |
| Piotroski F-Score | 1 |